Biotechnology - Genomic and Proteomics/IP Profile of Biggest for-profit companies in BGP: Difference between revisions

From Commons Based Research
Jump to navigation Jump to search
No edit summary
No edit summary
 
(33 intermediate revisions by 2 users not shown)
Line 1: Line 1:
Answer the questions:
{{TOCright}}


# What are the 10 biggest for-profit companies in this field?
=Introduction=
#*How is the market distributed?
#*Where are they located? Are there any incentives for specific locations?
#*Correlate them with their main outputs (Data. Narratives. Tools)
#*Understand and identify cases where these companies are “experimenting” or “adopting” commons-based approaches
#*Identify these cases and treat them as entities that will also be placed in our mapping*device (the quadrants)
#*Identify what companies are the “Microsofts” of the field and what companies are the “IBMs” of the field


{| class="prettytable"
The US biotechnology industry includes about 1,000 companies, with combined annual revenue close to $50 billion. Large companies include [http://www.amgen.com/ Amgen], [http://www.monsanto.com/ Monsanto], [http://www.gene.com/gene/index.jsp Genentech], and [http://www.biogenidec.com/ Biogen]. The biotechnology and the pharmaceutical industries overlap considerably, since many drugs are now developed using biotechnology. The industry consists of a few very large companies and many very small ones, and is fragmented by type of product. Most companies have annual sales under $50 million. 
|
| '''2006 Revenue ($m)'''
| '''Headquarters'''
| '''Primary Outputs'''
| '''Instances of Commons-based approaches'''


Industry overview here: [http://bio.org/speeches/pubs/er/statistics.asp Biotechnology Industry Organization]


Key Industry Statistics
Key Industry Figures 2008
* Industry Revenue: 85,695.4$Mil
* Revenue Growth: 12.9%
* Industry Gross Product: 58,539.2 $Mil
* Number of Establishments: 6,815 Units
* Number of Enterprises: 6,480 Units
* Employment: 341,000 Units
* Exports: 7,251$Mil
* Imports: 2,954.7$Mil
* Total Wages: *20,630.9$Mil
Source: [http://www.ibisworld.com/industry/retail.aspx?indid=2001&chid=1 Ibis World]


=[[BGP Company Profiles]]=
=[[Publishing Companies with focus on BGP]]=


|-
=Navigation=
| Amgen
* [[Bibliography for Item 6 in BGP]]<br>
| <div align="center">14268</div>
* [[Biotechnology_-_Genomic_and_Proteomics]]
| Thousand Oaks, California
| ten approved drugs for 15 conditions, 23 agents are being tested earlier in the approval pipeline
| ?
 
|-
| Genentech
 
 
 
| <div align="center">9284</div>
 
 
 
| South San Francisco
 
 
 
| synthetic human insulin - their first famous product, many others produced using the Boyer-Cohen rDNA process
| ?
 
|-
| Genzyme
 
 
 
| <div align="center">3187</div>
 
 
 
| Cambridge, Massachusetts
 
 
 
| Cerezyme (treats Gaucher's disease) accounts for 30% of company's revenue
| ?
 
|-
| Gilead Sciences
 
 
 
| <div align="center">3026</div>
 
 
 
| Foster City, California
| 11 commercial products
 
 
 
| ?
 
|-
| Biogen Idec
 
 
 
| <div align="center">2683</div>
 
 
 
| Cambridge, Massachusetts
 
 
 
| Treatments for Crohn's disease, non-Hodgkin's lymphoma, and multiple sclerosis
| ?
 
|-
| Cephalon
 
 
 
| <div align="center">1764</div>
 
 
 
| Frazer, Pennsylvania
| Specializes in treating neurodegenerative diseases
| ?
 
|-
| MedImmune
 
 
 
| <div align="center">1277</div>
 
 
 
| Gaithersburg, Maryland
| Only major drug prevents respiratory diseases in infants
| ?
 
|-
| Celgene
 
 
 
| <div align="center">899</div>
 
 
 
| Summit, New Jersey
 
 
 
| treatments for erythema nodosum leprosum ("ENL") and multiple myeloma
| ?
 
|-
| Abraxis BioScience
 
 
 
| <div align="center">766</div>
 
 
 
| Los Angeles, California
 
 
 
| uses patented nanoparticle technology to produce products for metastatic breast cancer
| ?
 
|-
| ImClone Systems
 
 
 
| <div align="center">678</div>
 
 
 
| New York, New York
 
 
 
| acquired by Eli Lilly, tried to produce Erbitux for Colorectal Cancer, but failed to win FDA approval
| ?
 
|}

Latest revision as of 19:40, 22 April 2010

Introduction

The US biotechnology industry includes about 1,000 companies, with combined annual revenue close to $50 billion. Large companies include Amgen, Monsanto, Genentech, and Biogen. The biotechnology and the pharmaceutical industries overlap considerably, since many drugs are now developed using biotechnology. The industry consists of a few very large companies and many very small ones, and is fragmented by type of product. Most companies have annual sales under $50 million.

Industry overview here: Biotechnology Industry Organization

Key Industry Statistics Key Industry Figures 2008

  • Industry Revenue: 85,695.4$Mil
  • Revenue Growth: 12.9%
  • Industry Gross Product: 58,539.2 $Mil
  • Number of Establishments: 6,815 Units
  • Number of Enterprises: 6,480 Units
  • Employment: 341,000 Units
  • Exports: 7,251$Mil
  • Imports: 2,954.7$Mil
  • Total Wages: *20,630.9$Mil

Source: Ibis World

BGP Company Profiles

Publishing Companies with focus on BGP

Navigation

Retrieved from "http://cyber.harvard.edu/commonsbasedresearch/?title=Biotechnology_-_Genomic_and_Proteomics/IP_Profile_of_Biggest_for-profit_companies_in_BGP&oldid=6898"